Bioavailability of transgenic microRNAs in genetically modified plants

Abstract Background Transgenic expression of small RNAs is a prevalent approach in agrobiotechnology for the global enhancement of plant foods. Meanwhile, emerging studies have, on the one hand, emphasized the potential of transgenic microRNAs (miRNAs) as novel dietary therapeutics and, on the other...

Full description

Bibliographic Details
Main Authors: Jian Yang, Cecilia Primo, Ismail Elbaz-Younes, Kendal D. Hirschi
Format: Article
Language:English
Published: BMC 2017-07-01
Series:Genes & Nutrition
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12263-017-0563-5
_version_ 1811280528586833920
author Jian Yang
Cecilia Primo
Ismail Elbaz-Younes
Kendal D. Hirschi
author_facet Jian Yang
Cecilia Primo
Ismail Elbaz-Younes
Kendal D. Hirschi
author_sort Jian Yang
collection DOAJ
description Abstract Background Transgenic expression of small RNAs is a prevalent approach in agrobiotechnology for the global enhancement of plant foods. Meanwhile, emerging studies have, on the one hand, emphasized the potential of transgenic microRNAs (miRNAs) as novel dietary therapeutics and, on the other, suggested potential food safety issues if harmful miRNAs are absorbed and bioactive. For these reasons, it is necessary to evaluate the bioavailability of transgenic miRNAs in genetically modified crops. Results As a pilot study, two transgenic Arabidopsis lines ectopically expressing unique miRNAs were compared and contrasted with the plant bioavailable small RNA MIR2911 for digestive stability and serum bioavailability. The expression levels of these transgenic miRNAs in Arabidopsis were found to be comparable to that of MIR2911 in fresh tissues. Assays of digestive stability in vitro and in vivo suggested the transgenic miRNAs and MIR2911 had comparable resistance to degradation. Healthy mice consuming diets rich in Arabidopsis lines expressing these miRNAs displayed MIR2911 in the bloodstream but no detectable levels of the transgenic miRNAs. Conclusions These preliminary results imply digestive stability and high expression levels of miRNAs in plants do not readily equate to bioavailability. This initial work suggests novel engineering strategies be employed to enhance miRNA bioavailability when attempting to use transgenic foods as a delivery platform.
first_indexed 2024-04-13T01:16:26Z
format Article
id doaj.art-3cd0978d7b1c4c369b555128f27b854f
institution Directory Open Access Journal
issn 1555-8932
1865-3499
language English
last_indexed 2024-04-13T01:16:26Z
publishDate 2017-07-01
publisher BMC
record_format Article
series Genes & Nutrition
spelling doaj.art-3cd0978d7b1c4c369b555128f27b854f2022-12-22T03:08:54ZengBMCGenes & Nutrition1555-89321865-34992017-07-011211810.1186/s12263-017-0563-5Bioavailability of transgenic microRNAs in genetically modified plantsJian Yang0Cecilia Primo1Ismail Elbaz-Younes2Kendal D. Hirschi3USDA/ARS Children’s Nutrition Research Center, Baylor College of MedicineUSDA/ARS Children’s Nutrition Research Center, Baylor College of MedicineUSDA/ARS Children’s Nutrition Research Center, Baylor College of MedicineUSDA/ARS Children’s Nutrition Research Center, Baylor College of MedicineAbstract Background Transgenic expression of small RNAs is a prevalent approach in agrobiotechnology for the global enhancement of plant foods. Meanwhile, emerging studies have, on the one hand, emphasized the potential of transgenic microRNAs (miRNAs) as novel dietary therapeutics and, on the other, suggested potential food safety issues if harmful miRNAs are absorbed and bioactive. For these reasons, it is necessary to evaluate the bioavailability of transgenic miRNAs in genetically modified crops. Results As a pilot study, two transgenic Arabidopsis lines ectopically expressing unique miRNAs were compared and contrasted with the plant bioavailable small RNA MIR2911 for digestive stability and serum bioavailability. The expression levels of these transgenic miRNAs in Arabidopsis were found to be comparable to that of MIR2911 in fresh tissues. Assays of digestive stability in vitro and in vivo suggested the transgenic miRNAs and MIR2911 had comparable resistance to degradation. Healthy mice consuming diets rich in Arabidopsis lines expressing these miRNAs displayed MIR2911 in the bloodstream but no detectable levels of the transgenic miRNAs. Conclusions These preliminary results imply digestive stability and high expression levels of miRNAs in plants do not readily equate to bioavailability. This initial work suggests novel engineering strategies be employed to enhance miRNA bioavailability when attempting to use transgenic foods as a delivery platform.http://link.springer.com/article/10.1186/s12263-017-0563-5Dietary microRNAsGenetically modified organismsBioavailabilityDigestive stabilityMIR2911Mice
spellingShingle Jian Yang
Cecilia Primo
Ismail Elbaz-Younes
Kendal D. Hirschi
Bioavailability of transgenic microRNAs in genetically modified plants
Genes & Nutrition
Dietary microRNAs
Genetically modified organisms
Bioavailability
Digestive stability
MIR2911
Mice
title Bioavailability of transgenic microRNAs in genetically modified plants
title_full Bioavailability of transgenic microRNAs in genetically modified plants
title_fullStr Bioavailability of transgenic microRNAs in genetically modified plants
title_full_unstemmed Bioavailability of transgenic microRNAs in genetically modified plants
title_short Bioavailability of transgenic microRNAs in genetically modified plants
title_sort bioavailability of transgenic micrornas in genetically modified plants
topic Dietary microRNAs
Genetically modified organisms
Bioavailability
Digestive stability
MIR2911
Mice
url http://link.springer.com/article/10.1186/s12263-017-0563-5
work_keys_str_mv AT jianyang bioavailabilityoftransgenicmicrornasingeneticallymodifiedplants
AT ceciliaprimo bioavailabilityoftransgenicmicrornasingeneticallymodifiedplants
AT ismailelbazyounes bioavailabilityoftransgenicmicrornasingeneticallymodifiedplants
AT kendaldhirschi bioavailabilityoftransgenicmicrornasingeneticallymodifiedplants